Clinical Trial Update: A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy of a bortezomib-based regimen (bortezomib with doxorubicin and dexamethasone) in previously untreated multiple myeloma pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Adriamycin (doxorubicin)
• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Janssen-Cilag Pty Ltd | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2013-05-07